| Literature DB >> 33649861 |
Haibo Zhang1, Song Park2, Hai Huang1, Eungyung Kim1, Junkoo Yi3, Seong-Kyoon Choi2, Zaeyoung Ryoo4, Myoungok Kim1.
Abstract
Ginsenoside Rh2 (G‑Rh2) is a natural bioactive product derived from Panax ginseng Meyer (P. ginseng). G‑Rh2 exhibits anticancer activity in various human cancer cell lines both in vitro and in vivo by modulating several signaling pathways, such as those of PDZ‑binding kinase/T‑LAK cell‑originated protein kinase, phosphatidylinositol 3‑kinase, protein kinase B, mammalian target of rapamycin, epidermal growth factor receptor, p53, and reactive oxygen species. Moreover, G‑Rh2 could effectively reverse drug resistance and enhance therapeutic effects in cancer therapy. This review summarizes the chemical properties, in vitro and in vivo anticancer activity, and underlying molecular mechanisms of G‑Rh2 to facilitate cancer chemoprevention studies.Entities:
Year: 2021 PMID: 33649861 DOI: 10.3892/or.2021.7984
Source DB: PubMed Journal: Oncol Rep ISSN: 1021-335X Impact factor: 3.906